-

AstroNova Reports Fourth-Quarter and Full-Year Fiscal 2026 Financial Results

  • Fourth quarter revenue of $37.5 million and fiscal 2026 revenue of $150.5 million, in line with guidance
  • Fourth quarter net loss was $1.1 million, or $0.15 per diluted share; adjusted EBITDA1 was $3.3 million, or 8.8% of sales
  • Product Identification turnaround gaining momentum with well-defined go-to-market and operations strategies
  • Total orders in the quarter were up 6.5% to $41.1 million
  • Generated $3.7 million of operating cash in the quarter and $11.7 million for the full year, compared with $2.5 million and $4.8 million in the prior periods, respectively
  • Strengthened balance sheet with debt reduced by $2.7 million in the quarter and $9.1 million in fiscal 2026
  • Previously announced evaluation of strategic alternatives

WEST WARWICK, R.I.--(BUSINESS WIRE)--AstroNova, Inc. (Nasdaq: ALOT), a leading innovator in specialized print technology solutions, today announced financial results for its fiscal 2026 fourth quarter and full-year ended January 31, 2026.

Jorik Ittmann, President and Chief Executive Officer of AstroNova, stated, "The second half of fiscal 2026 was a reset period for AstroNova. As we began the year, we recognized that the changes we were making in the business would begin to be realized with a stronger second half. Our focus was on stabilizing the business and ending the year having generated more cash, reduced debt, and raised accountability across both segments. Our Aerospace business delivered a strong performance, with ToughWriter now representing more than 80% of total flight deck printer shipments, positioning us well as aircraft build rates increase.

“In Product ID, we provide label printing solutions that address the needs of three key verticals: healthcare/life sciences, industrial and chemical industries. In these markets our labels are a component of customers’ products and are critical to their success. Our restructuring efforts are being realized through improving commercial momentum in these verticals. We have employed more robust analytics to understand our customers and markets and are better directing our resources to drive growth. This includes continuing to evolve the team, putting the right talent in the correct roles, and recognizing where and why we can win. We expect this focus of our resources where we have competitive advantages will lead to stronger, more profitable growth."

Mr. Ittmann added, "Looking ahead to fiscal 2027, we expect Aerospace to deliver measured growth, supported by rising aircraft production, a favorable product mix, and the expiration of a major royalty obligation during the third quarter of the year that negatively impacts gross margin on an annualized basis by approximately $2 million. In Product ID, we are focused on converting our commercial pipeline into consistent revenue growth while strengthening operational performance. We believe we can create greater value for our shareholders with our enhanced product offerings, go-to-market strategy and operational restructuring. Importantly, we will evaluate all strategic alternatives to achieve this goal."

Fourth Quarter Fiscal 2026 Overview1 (comparisons are to the prior-year period unless noted otherwise)

 
Three Months Ended 2H Fiscal 2026 compared with 1H Fiscal 2026
January 31,
2026
January 31,
2025
$
Variance
%
Variance
2H FY26 1H FY26 $
Variance
%
Variance
Revenue

$

37,536

$

37,361

$

175

0.5%

$

76,705

$

73,810

$

2,895

3.9%

Gross Profit

$

11,325

$

12,226

$

(901)

(7.4)%

$

24,769

$

22,865

$

1,902

8.3%

Gross Profit Margin

 

30.2%

 

32.7%

 

32.3%

 

31.0%

Non-GAAP Gross Profit

$

11,903

$

12,289

$

(386)

(3.1)%

$

25,707

$

23,264

$

2,444

10.5%

Non-GAAP Gross Profit Margin

 

31.7%

 

32.9%

 

33.5%

 

31.5%

Operating Income (Loss)

$

56

$

(12,311)

$

12,367

(100.5)%

$

1,342

$

(137)

$

1,479

N/A

Operating Margin

 

0.1%

 

(33.0)%

 

1.7%

 

(0.2)%

Non-GAAP Operating Income

$

1,124

$

1,408

$

(284)

(20.2)%

$

3,688

$

1,906

$

1,781

93.4%

Non-GAAP Operating Income Margin

 

3.0%

 

3.8%

 

4.8%

 

2.6%

Net Income (Loss)

$

(1,134)

$

(15,600)

$

14,466

(92.7)%

$

(756)

$

(1,620)

$

864

53.3%

Non-GAAP Net Income (Loss)

$

(305)

$

419

$

(724)

(172.7)%

$

1,277

$

(59)

$

1,336

N/A

Adjusted EBITDA

$

3,306

$

2,794

$

512

18.3%

$

7,478

$

5,202

$

2,276

43.7%

Adjusted EBITDA Margin

 

8.8%

 

7.5%

 

9.7%

 

7.0%

______________________________ 

1 Non-GAAP gross profit, Non-GAAP gross profit margin, Non-GAAP operating income, Non-GAAP operating income margin, Non-GAAP net income, adjusted EBITDA and adjusted EBITDA margin are Non-GAAP financial measures.  Refer to the reconciliation of GAAP to non-GAAP measures in the tables that accompany this news release.

Compared with the prior-year period, revenue increased $0.2 million as growth in Product ID slightly exceeded lower Aerospace revenue. Tariff mitigation contributed $0.6 million in revenue and foreign currency translation was a $0.8 million benefit in the quarter.

As a result of lower volume and mix, gross profit decreased $0.9 million, or 7.4%, and gross margin contracted 250 basis points compared with the prior-year period. On an adjusted basis, gross margin contracted 120 basis points from the prior-year period to 32.9%.

Operating expenses in the quarter were $11.3 million down from $25.0 million in the prior-year period. The prior year period included a goodwill impairment charge of $13.4 million. Operating income for the quarter was $56 thousand compared with operating loss of $12.3 million in the prior-year period, while non-GAAP operating income was $1.1 million, down $0.3 million compared with the prior-year period.

Interest expense of $0.9 million was nominally unchanged from the prior-year period. Net loss of $1.1 million, or $0.15 per share, compared with net loss of $15.6 million in the prior-year period, which included a goodwill impairment charge of $13.4 million. Non-GAAP net loss was $0.3 million, or $0.04 per share. Adjusted EBITDA was $3.3 million and Adjusted EBITDA margin was 8.8%.

Beginning in the fourth quarter of fiscal 2026, the Company revised its segment reporting methodology to allocate related general and administrative expenses directly to the reportable segments, Product Identification and Aerospace. Management believes this change better reflects the true operating performance of each segment. Prior period segment results have been recast to reflect this change. The impact of this reallocation on segment operating income is presented in the segment tables that follow.

Product Identification (Product ID) Segment Review

Product ID revenue was $26.3 million for the fourth quarter of fiscal 2026, up 2.5%, or $0.7 million, compared with the prior year. Aftermarket revenue remained strong, representing approximately 80% of total segment sales.

Product ID segment operating loss was $0.2 million, an improvement from the segment operating loss of $13.1 million in the prior-year period which included the previously mentioned goodwill impairment charge. Non-GAAP segment operating loss was $0.1 million, or -0.5% of revenue.

Aerospace Segment Review

Aerospace segment revenue was $11.2 million in the fiscal 2026 fourth quarter, a decrease of 4.1%, or $0.5 million from the prior-year, primarily as a result of the timing of projects.

Despite lower sales, Aerospace segment operating profit was $2.3 million, up $0.5 million, or 24.0%, over the prior-year period as a result of improved mix.

Balance Sheet and Cash Flow

Cash from operations in the fourth quarter of fiscal 2026 was $3.7 million and was $11.7 million year to date. The improvement in cash generation in the quarter was primarily the result of reduced working capital requirements, primarily due to lower inventory.

Capital expenditures in the quarter were $139 thousand and $332 thousand for fiscal 2026 compared with $79 thousand and $1.2 million, respectively, in the prior year.

Cash at the end of the fourth quarter of fiscal 2026 was $4.1 million, down $0.9 million from the end of fiscal 2025. Debt as of January 31, 2026 was $37.6 million compared with $46.7 million as of January 31, 2025.

Bookings and Backlog by Segment

Orders in the quarter for the Product ID segment were $27.5 million, up $2.9 million compared with the prior-year period as the Company’s new go-to-market strategy gained traction. The book-to-bill ratio for the segment was 104% and backlog at the end of fiscal 2026 was $13.5 million.

Orders in the quarter for the Aerospace segment were $13.6 million for a book-to-bill ratio of 122% reflecting demand from OEMs for new-build aircraft. Backlog at the end of fiscal 2026 was $12.0 million.

Fiscal 2027 Outlook

“We are making solid progress with the improvement in our Product ID segment and are delivering on the potential of the Aerospace segment. As noted previously, a major royalty obligation for Aerospace will expire in the third quarter this year that will provide an annualized contribution to gross profit of approximately $2 million beginning in the fourth quarter. We are encouraged with our progress and believe we are creating greater opportunity for the business,” concluded Mr. Ittmann.

For fiscal 2027, AstroNova expects mid-single digit revenue growth and expanded adjusted EBITDA margin.

Earnings Conference Call Information

AstroNova will host a conference call and webcast at 8:30 a.m. ET on Tuesday, April 14, 2026, to review financial and operating results for the fourth quarter and full year of fiscal 2026. A question and answer session will follow.

To access the conference call, please dial (201) 689-8560 or find the webcast and accompanying slide presentation at https://investors.astronovainc.com/investors/events-and-presentations/default.aspx.

A telephonic replay will be available from 12:00 p.m. ET on the day of the call through Tuesday, April 28, 2026. To listen to the archived call, dial (412) 317-6671 and enter a replay PIN 13759000. The webcast replay will be available on the Investor Relations section of the Company’s website where a transcript will be posted once available.

About AstroNova, Inc.

AstroNova (Nasdaq: ALOT) is a global provider of printing technologies serving regulated and industrial markets. The Company designs, manufactures, distributes, and services solutions that enable customers to identify, track, and communicate essential product and safety information across a wide range of applications and media. AstroNova supports customers by enabling safety, accuracy and durability for flight deck communications, medical device and healthcare products, essential chemical products, and mission-critical industrial components, while ensuring compliance with local and regional regulatory requirements.

The Product Identification segment delivers end-to-end marking and identification solutions, including hardware, software, and consumables for OEMs, commercial printers, and brand owners. These solutions are used across labels, flexible packaging, corrugated, and industrial substrates, where durability, traceability, and compliance are essential. The Aerospace segment is a global leader in providing products designed for airborne printing solutions, avionics, and data acquisition, including flight deck printing solutions, networking hardware, and specialized aerospace-grade supplies. For more information please visit: www.astronovainc.com.

Use of Non-GAAP Financial Measures
In addition to financial measures prepared in accordance with generally accepted accounting principles (GAAP), this news release contains the Non-GAAP financial measures: Non-GAAP gross profit, Non-GAAP gross profit margin, Non-GAAP operating expenses, Non-GAAP operating income, Non-GAAP operating income margin, Non-GAAP net income (loss), Non-GAAP net income per Common Share - diluted, Non-GAAP segment gross profit, Non-GAAP segment gross profit margin, Non-GAAP segment operating income, Non-GAAP segment operating margin, Adjusted EBITDA and Adjusted EBITDA Margin. AstroNova believes that the inclusion of these Non-GAAP financial measures helps investors gain a meaningful understanding of changes in the Company’s core operating results and can help investors who wish to make comparisons between AstroNova and other companies on both a GAAP and a Non-GAAP basis. AstroNova’s management uses these Non-GAAP financial measures, in addition to GAAP financial measures, as the basis for measuring its core operating performance and comparing such performance to that of prior periods and to the performance of its competitors. These measures are also used by the Company’s management to assist with their financial and operating decision-making. Please refer to the financial reconciliation table included in this news release for a reconciliation of the Non-GAAP measures to the most directly comparable GAAP measures for the three months ended January 31, 2026 and 2025 as well as the years ended January 31, 2026 and 2025.

Forward-Looking Statements
Information included in this news release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are not statements of historical fact but rather reflect our current expectations concerning future events and results. These statements may include the use of the words “believes,” “expects,” “intends,” “plans,” “anticipates,” “likely,” “continues,” “may,” “will,” and similar expressions to identify forward-looking statements. Such forward-looking statements, including those concerning the Company’s anticipated performance, involve risks, uncertainties and other factors, some of which are beyond our control, which may cause our actual results, performance or achievements to be materially different from those expressed or implied by such forward-looking statements. These risks, uncertainties and factors include, but are not limited to, (i) the risk that our efforts to improve sales in our Product Identification segment may not result in the benefits we expect, (ii) the risk that our Aerospace customers may not continue to convert to our ToughWriter® printer in the volumes or on the schedule that we expect; (iii) the risk that we may not realize the anticipated benefits of our next-generation print engine technology; and (iv) those factors set forth in the Company’s Annual Report on Form 10-K for the fiscal year ended January 31, 2025 and subsequent filings AstroNova makes with the Securities and Exchange Commission. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. The reader is cautioned not to unduly rely on such forward-looking statements when evaluating the information presented in this news release.

ASTRONOVA, INC.
Condensed Consolidated Statements of Income (Loss)

(In thousands, except per share data)

(Unaudited)

   
Three Months Ended
January 31,
2026
January 31,
2025
$ Variance % Variance
Revenue

$

37,536

 

$

37,361

 

$

175

 

0.5

%

Cost of Revenue

 

26,211

 

 

25,135

 

 

1,076

 

4.3

%

Gross Profit

 

11,325

 

 

12,226

 

 

(901

)

(7.4

)%

Total Gross Profit Margin

 

30.2

%

 

32.7

%

Operating Expenses:
Selling & Marketing

 

5,642

 

 

6,097

 

 

(455

)

(7.5

)%

Research & Development

 

1,797

 

 

1,617

 

 

180

 

11.1

%

General & Administrative

 

3,830

 

 

3,420

 

 

410

 

12.0

%

Goodwill Impairment

 

 

 

13,403

 

 

(13,403

)

(100.0

)%

Total Operating Expenses

 

11,269

 

 

24,537

 

 

(13,268

)

(54.1

)%

Operating Income (Loss)

 

56

 

 

(12,311

)

 

12,367

 

(100.5

)%

Total Operating Margin

 

0.1

%

 

(33.0

)%

Interest Expense

 

894

 

 

847

 

 

47

 

5.5

%

Other (Income)/Expense, net

 

(51

)

 

100

 

 

(151

)

(151.0

)%

Income (Loss) Before Taxes

 

(788

)

 

(13,258

)

 

12,470

 

(94.1

)%

Income Tax Provision (Benefit)

 

346

 

 

2,342

 

 

(1,996

)

(85.2

)%

Net Income (Loss)

$

(1,134

)

$

(15,600

)

$

14,466

 

(92.7

)%

Net Income (Loss) per Common Share - Basic

$

(0.15

)

$

(2.07

)

Net Income (Loss) per Common Share - Diluted

$

(0.15

)

$

(2.07

)

 
Weighted Average Number of Common Shares - Basic

 

7,653

 

 

7,534

 

Weighted Average Number of Common Shares - Diluted

 

7,653

 

 

7,534

 

Twelve Months Ended
January 31,
2026
January 31,
2025
$ Variance % Variance
Revenue

$

150,515

 

$

151,283

 

$

(768

)

(0.5

)%

Cost of Revenue

 

102,881

 

 

100,625

 

 

2,256

 

2.2

%

Gross Profit

 

47,634

 

 

50,658

 

 

(3,024

)

(6.0

)%

Total Gross Profit Margin

 

31.6

%

 

33.5

%

Operating Expenses:
Selling & Marketing

 

22,963

 

 

24,252

 

 

(1,289

)

(5.3

)%

Research & Development

 

6,788

 

 

6,047

 

 

741

 

12.3

%

General & Administrative

 

16,380

 

 

15,596

 

 

784

 

5.0

%

Goodwill Impairment

 

297

 

 

13,403

 

 

(13,106

)

(97.8

)%

Total Operating Expenses

 

46,428

 

 

59,298

 

 

(12,870

)

(21.7

)%

Operating Income (Loss)

 

1,206

 

 

(8,640

)

 

9,846

 

(114.0

)%

Total Operating Margin

 

0.8

%

 

(5.7

)%

Interest Expense

 

3,503

 

 

3,210

 

 

293

 

9.1

%

Other (Income)/Expense, net

 

239

 

 

437

 

 

(198

)

(45.3

)%

Income (Loss) Before Taxes

 

(2,536

)

 

(12,287

)

 

9,751

 

(79.4

)%

Income Tax Provision (Benefit)

 

(160

)

 

2,202

 

 

(2,362

)

(107.3

)%

Net Income (Loss)

$

(2,376

)

$

(14,489

)

$

12,113

 

(83.6

)%

Net Income (Loss) per Common Share - Basic

$

(0.31

)

$

(1.93

)

Net Income (Loss) per Common Share - Diluted

$

(0.31

)

$

(1.93

)

 
Weighted Average Number of Common Shares - Basic

 

7,614

 

 

7,509

 

Weighted Average Number of Common Shares - Diluted

 

7,614

 

 

7,509

 

ASTRONOVA, INC.

Condensed Consolidated Balance Sheets

(In thousands)

(Unaudited)

 
January 31,
2026
January 31,
2025
ASSETS
CURRENT ASSETS
Cash and Cash Equivalents

$

4,072

 

$

5,050

 

Accounts Receivable, net

 

18,985

 

 

21,218

 

Inventories, net

 

43,252

 

 

47,894

 

Prepaid Expenses and Other Current Assets

 

4,395

 

 

3,855

 

Total Current Assets

 

70,704

 

 

78,017

 

PROPERTY, PLANT AND EQUIPMENT

 

40,400

 

 

58,613

 

Less Accumulated Depreciation

 

(26,272

)

 

(42,820

)

Property, Plant and Equipment, net

 

14,128

 

 

15,793

 

OTHER ASSETS
Identifiable Intangibles, net

 

21,496

 

 

23,519

 

Goodwill

 

17,376

 

 

16,361

 

Deferred Tax Assets, net

 

9,831

 

 

8,431

 

Right of Use Asset

 

2,466

 

 

1,781

 

Other Assets

 

1,565

 

 

1,693

 

TOTAL ASSETS

$

137,566

 

$

145,595

 

LIABILITIES AND SHAREHOLDERS’ EQUITY
CURRENT LIABILITIES
Accounts Payable

$

6,806

 

$

7,928

 

Accrued Compensation

 

4,390

 

 

3,745

 

Other Accrued Expenses

 

4,702

 

 

4,461

 

Revolving Line of Credit

 

16,273

 

 

20,929

 

Current Portion of Long-Term Debt

 

3,033

 

 

6,110

 

Short-Term Debt

 

-

 

 

581

 

Current Liability – Royalty Obligation

 

1,656

 

 

1,358

 

Current Liability – Excess Royalty Payment Due

 

331

 

 

691

 

Income Taxes Payable

 

691

 

 

-

 

Deferred Revenue

 

489

 

 

543

 

Total Current Liabilities

 

38,371

 

 

46,346

 

NON-CURRENT LIABILITIES
Long-Term Debt, net of current portion

 

18,295

 

 

19,044

 

Lease Liabilities, net of current portion

 

1,953

 

 

1,535

 

Grant Deferred Revenue

 

899

 

 

1,090

 

Royalty Obligation, net of current portion

 

145

 

 

1,106

 

Income Tax Payables

 

800

 

 

684

 

Deferred Tax Liabilities

 

-

 

 

40

 

Other Long-Term Liability

 

241

 

 

-

 

TOTAL LIABILITIES

 

60,704

 

 

69,845

 

SHAREHOLDERS’ EQUITY
Common Stock

 

554

 

 

547

 

Additional Paid-in Capital

 

66,329

 

 

64,215

 

Retained Earnings

 

47,004

 

 

49,380

 

Treasury Stock

 

(35,227

)

 

(35,043

)

Accumulated Other Comprehensive Loss, net of tax

 

(1,798

)

 

(3,349

)

TOTAL SHAREHOLDERS’ EQUITY

 

76,862

 

 

75,750

 

TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY

$

137,566

 

$

145,595

 

ASTRONOVA, INC.

Condensed Consolidated Statements of Cash Flow – Three Months

(In thousands)

(Unaudited)

  
Three Months Ended
January 31, 2026 January 31, 2025
Cash Flows from Operating Activities:
Net Income (Loss)

$

(1,134

)

$

(15,599

)

Adjustments to Reconcile Net Income (Loss) to Net Cash Provided by Operating Activities:
Depreciation and Amortization

 

1,379

 

 

1,266

 

Grant Income Included in Depreciation

 

155

 

 

51

 

Goodwill Impairment

 

-

 

 

13,403

 

Amortization of Debt Issuance Costs

 

10

 

 

8

 

Share-Based Compensation

 

751

 

 

219

 

Deferred Income Tax Provision (Benefit)

 

(1,238

)

 

874

 

Loss on Disposal of Fixed Assets

 

3

 

 

-

 

Changes in Assets and Liabilities:
Accounts Receivable

 

1,566

 

 

1,240

 

Inventories

 

2,129

 

 

236

 

Income Taxes

 

1,764

 

 

630

 

Accounts Payable and Accrued Expenses

 

(758

)

 

(8

)

Deferred Revenue

 

(519

)

 

(440

)

Other

 

(434

)

 

645

 

Net Cash Provided by Operating Activities

$

3,673

 

$

2,525

 

 
Cash Flows from Investing Activities:
Proceeds from Sale of Equipment

 

13

 

 

-

 

Purchases of Property, Plant and Equipment

 

(139

)

 

(79

)

Cash Paid for MTEX Acquisition, net of cash acquired

 

-

 

 

-

 

Net Cash Used for Investing Activities

$

(126

)

$

(79

)

 
Cash Flows from Financing Activities:
Net Cash Proceeds from Employee Stock Option Plans

 

-

 

 

-

 

Net Cash Proceeds from Share Purchases under Employee Stock Purchase Plan

 

-

 

 

48

 

Net Cash Used for Payment of Taxes Related to Vested Restricted Stock

 

(1

)

 

(18

)

Revolving Credit Facility, net

 

(1,981

)

 

734

 

Proceeds from Long Term Debt Borrowings

 

-

 

 

-

 

Payment of Minimum Guarantee Royalty Obligation

 

(279

)

 

(655

)

Principal Payments of Long-Term Debt

 

(864

)

 

(2,274

)

Payments of Debt Issuance Costs

 

-

 

 

3

 

Net Cash Provided by (Used for) Financing Activities

$

(3,125

)

$

(2,163

)

 
Effect of Exchange Rate Changes on Cash and Cash Equivalents

 

44

 

 

336

 

Net Increase in Cash and Cash Equivalents

$

466

 

$

618

 

Cash and Cash Equivalents, Beginning of Period

 

3,606

 

 

4,432

 

Cash and Cash Equivalents, End of Period

$

4,072

 

$

5,050

 

 
Supplemental Information:
Cash Paid During the Period for:
Interest

$

751

 

$

810

 

Income Taxes, net of refunds

 

13

 

 

707

 

Non-Cash Transactions:
Operating Lease Obtained in Exchange for Operating Lease Liabilities

$

89

 

$

-

 

ASTRONOVA, INC.

Condensed Consolidated Statements of Cash Flow – Twelve Months

(In thousands)

(Unaudited)

 
Twelve Months Ended
January 31, 2026 January 31, 2025
Cash Flows from Operating Activities:
Net Income (Loss)

$

(2,376

)

$

(14,489

)

Adjustments to Reconcile Net Income (Loss) to Net Cash Provided by Operating Activities:
Depreciation and Amortization

 

4,804

 

 

4,780

 

Grant Income Included in Depreciation

 

330

 

 

159

 

Goodwill Impairment

 

297

 

 

13,403

 

Amortization of Debt Issuance Costs

 

43

 

 

30

 

Share-Based Compensation

 

2,310

 

 

1,378

 

Deferred Income Tax Provision (Benefit)

 

(1,312

)

 

874

 

Loss on Disposal of Fixed Assets

 

115

 

 

-

 

Changes in Assets and Liabilities:
Accounts Receivable

 

2,786

 

 

2,859

 

Inventories

 

5,909

 

 

1,616

 

Income Taxes

 

663

 

 

(904

)

Accounts Payable and Accrued Expenses

 

(1,125

)

 

(2,379

)

Deferred Revenue

 

(420

)

 

(1,520

)

Other

 

(286

)

 

(959

)

Net Cash Provided by Operating Activities

$

11,738

 

$

4,848

 

 
Cash Flows from Investing Activities:
Proceeds from Sale of Equipment

 

113

 

 

-

 

Purchases of Property, Plant and Equipment

 

(332

)

 

(1,165

)

Cash Paid for MTEX Acquisition, net of cash acquired

 

-

 

 

(19,109

)

Net Cash Used for Investing Activities

$

(219

)

$

(20,274

)

 
Cash Flows from Financing Activities:
Net Cash Proceeds from Employee Stock Option Plans

 

-

 

 

12

 

Net Cash Proceeds from Share Purchases under Employee Stock Purchase Plan

 

51

 

 

146

 

Net Cash Used for Payment of Taxes Related to Vested Restricted Stock

 

(184

)

 

(450

)

Revolving Credit Facility, net

 

(5,158

)

 

11,508

 

Proceeds from Long Term Debt Borrowings

 

19,720

 

 

15,078

 

Payment of Minimum Guarantee Royalty Obligation

 

(1,238

)

 

(1,902

)

Principal Payments of Long-Term Debt

 

(25,982

)

 

(8,980

)

Payments of Debt Issuance Costs

 

(66

)

 

(34

)

Net Cash Provided by (Used for) Financing Activities

$

(12,857

)

$

15,378

 

 
Effect of Exchange Rate Changes on Cash and Cash Equivalents

 

360

 

 

571

 

Net (Decrease) Increase in Cash and Cash Equivalents

$

(978

)

$

523

 

Cash and Cash Equivalents, Beginning of Period

 

5,050

 

 

4,527

 

Cash and Cash Equivalents, End of Period

$

4,072

 

$

5,050

 

 
Supplemental Information:
Cash Paid During the Period for:
Interest

$

3,043

 

$

2,701

 

Income Taxes, net of refunds

 

634

 

 

2,210

 

Non-Cash Transactions:
Operating Lease Obtained in Exchange for Operating Lease Liabilities

$

1,075

 

$

1,581

 

ASTRONOVA, INC.
Segment Sales and Profit
(Unaudited, $ in thousands)

 

 
Three Months
Ended
Twelve Months
Ended
($ in thousands) January 31,
2026
January 31,
2025
January 31,
2026
January 31,
2025
Revenue:
Product ID

$

26,330

 

$

25,678

 

$

104,221

 

$

102,345

 

Aerospace

 

11,206

 

 

11,683

 

 

46,294

 

 

48,938

 

Total Revenue

$

37,536

 

$

37,361

 

$

150,515

 

$

151,283

 

 
Gross Profit:
Product ID

$

7,088

 

$

8,237

 

$

29,837

 

$

32,571

 

Aerospace

 

4,237

 

 

3,989

 

 

17,797

 

 

18,087

 

Gross Profit

$

11,325

 

$

12,226

 

$

47,634

 

$

50,658

 

 
Gross Profit Margin:
Product ID

 

26.9

%

 

32.1

%

 

28.6

%

 

31.8

%

Aerospace

 

37.8

%

 

34.1

%

 

38.4

%

 

37.0

%

Gross Profit Margin

 

30.2

%

 

32.7

%

 

31.6

%

 

33.5

%

 
Segment Operating Income:
Product ID

$

(234

)

$

(13,076

)

$

(472

)

$

(11,860

)

Aerospace

 

2,337

 

 

1,885

 

 

9,763

 

 

9,087

 

Total Segment Operating Income

$

2,103

 

$

(11,191

)

$

9,291

 

$

(2,773

)

 
Segment Operating Margin:
Product ID

 

-0.9

%

 

-50.9

%

 

-0.5

%

 

-11.6

%

Aerospace

 

20.9

%

 

16.1

%

 

21.1

%

 

18.6

%

Total Segment Operating Margin

 

5.6

%

 

-30.0

%

 

6.2

%

 

-1.8

%

 
Corporate Expense

 

(2,049

)

 

(1,120

)

 

(8,085

)

 

(5,867

)

Operating Income (Loss)

$

54

 

$

(12,311

)

$

1,206

 

$

(8,640

)

Interest Expense

$

894

 

$

847

 

$

3,503

 

$

3,210

 

Other (Income)/Expense, net

 

(51

)

 

100

 

 

239

 

 

437

 

Income (Loss) Before Income Taxes

$

(788

)

$

(13,259

)

$

(2,536

)

$

(12,287

)

Income Tax Provision (Benefit)

 

346

 

 

2,342

 

 

(160

)

 

2,202

 

Net Income (Loss)

$

(1,134

)

$

(15,600

)

$

(2,376

)

$

(14,489

)

ASTRONOVA, INC.
Segment Sales and Non-GAAP Profit
(Unaudited, $ in thousands)

 

 
Three Months
Ended
Twelve Months
Ended
($ in thousands) January 31,
2026
January 31,
2025
January 31,
2026
January 31,
2025
Revenue:
Product ID

$

26,330

 

$

25,678

 

$

104,221

 

$

102,345

 

Aerospace

 

11,206

 

 

11,683

 

 

46,294

 

 

48,938

 

Total Revenue

$

37,536

 

$

37,361

 

$

150,515

 

$

151,283

 

 
Non-GAAP Gross Profit:
Product ID

$

7,356

 

$

8,296

 

$

31,010

 

$

32,770

 

Aerospace

 

4,547

 

 

3,989

 

 

17,961

 

 

18,087

 

Non-GAAP Gross Profit

$

11,903

 

$

12,285

 

$

48,971

 

$

50,857

 

 
Non-GAAP Gross Profit Margin:
Product ID

 

27.9

%

 

32.3

%

 

29.8

%

 

32.0

%

Aerospace

 

40.6

%

 

34.1

%

 

38.8

%

 

37.0

%

Non-GAAP Gross Profit Margin

 

31.7

%

 

32.9

%

 

32.5

%

 

33.6

%

 
Non-GAAP Segment Operating Income:
Product ID

$

(124

)

$

647

 

$

1,542

 

$

2,966

 

Aerospace

 

2,648

 

 

1,886

 

 

9,934

 

 

9,088

 

Total Non-GAAP Segment Operating Income

$

2,524

 

$

2,533

 

$

11,476

 

$

12,054

 

 
Non-GAAP Segment Operating Margin:
Product ID

 

-0.5

%

 

2.5

%

 

1.5

%

 

2.9

%

Aerospace

 

23.6

%

 

16.1

%

 

21.5

%

 

18.6

%

Total Non-GAAP Segment Operating Margin

 

6.7

%

 

6.8

%

 

7.6

%

 

8.0

%

 
Corporate Expense

 

(1,400

)

 

(1,123

)

 

(5,882

)

 

(5,437

)

Non-GAAP Operating Income

$

1,124

 

$

1,409

 

$

5,594

 

$

6,617

 

Interest Expense

$

894

 

$

847

 

$

3,503

 

$

3,210

 

Other (Income)/Expense, net

 

(51

)

 

100

 

 

28

 

 

437

 

Income Before Income Taxes

$

281

 

$

462

 

$

2,063

 

$

2,970

 

Adjusted Income Tax Provision (Benefit)

 

586

 

 

43

 

 

845

 

 

284

 

Non-GAAP Net Income

$

(305

)

$

419

 

$

1,218

 

$

2,686

 

ASTRONOVA, INC.
Revenue by Market

(unaudited, $ in thousands)

 

Product ID: Q1 FY25   Q2 FY25   Q3 FY25   Q4 FY25   FY2025   Q1 FY26   Q2 FY26   Q3 FY26   Q4 FY26   FY2026
Desktop Label Printers

$

14,220

 

$

16,349

 

$

15,408

 

$

14,019

 

$

59,996

 

$

15,478

 

$

15,190

 

$

16,115

 

 

15,041

 

 

61,824

Mail & Sheet/Flat Pack Printers

 

3,930

 

 

3,471

 

 

3,679

 

 

4,494

 

 

15,574

 

 

4,050

 

 

3,740

 

 

4,280

 

 

4,138

 

 

16,208

Professional Label Printers

 

3,245

 

 

4,231

 

 

3,423

 

 

2,972

 

 

13,871

 

 

3,247

 

 

3,506

 

 

3,636

 

 

3,863

 

 

14,252

Direct to Package/Overprint Printers

 

1,787

 

 

2,925

 

 

3,627

 

 

2,718

 

 

11,057

 

 

3,396

 

 

2,230

 

 

2,371

 

 

2,579

 

 

10,576

Flexible Packaging Printers

 

-

 

 

-

 

 

15

 

 

1,289

 

 

1,304

 

 

30

 

 

69

 

 

79

 

 

38

 

 

216

Other

 

3

 

 

189

 

 

165

 

 

186

 

 

543

 

 

88

 

 

19

 

 

368

 

 

670

 

 

1,145

TOTAL

$

23,185

 

$

27,165

 

$

26,317

 

$

25,678

 

$

102,345

 

$

26,289

 

$

24,754

 

$

26,849

 

 

26,330

 

 

104,221

                   
Aerospace: Q1 FY25   Q2 FY25   Q3 FY25   Q4 FY25   FY2025   Q1 FY26*   Q2 FY26   Q3 FY26   Q4 FY26   FY2026
Commercial Aircraft

 

3,813

 

 

6,299

 

 

5,221

 

 

4,363

 

 

19,696

 

 

4,953

 

 

4,714

 

 

5,764

 

 

5,030

 

 

20,461

Aftermarket

$

4,694

 

$

5,326

 

$

7,058

 

$

5,481

 

$

22,559

 

$

4,911

 

$

4,953

 

$

4,955

 

$

4,831

 

$

19,650

Defense

 

329

 

 

608

 

 

734

 

 

781

 

 

2,452

 

 

811

 

 

1,047

 

 

766

 

 

885

 

 

3,509

Regional and Biz Jet Aircraft

 

697

 

 

604

 

 

993

 

 

802

 

 

3,096

 

 

396

 

 

431

 

 

634

 

 

195

 

 

1,656

Other

 

243

 

 

537

 

 

99

 

 

256

 

 

1,135

 

 

348

 

 

203

 

 

201

 

 

266

 

 

1,018

TOTAL

$

9,776

 

$

13,374

 

$

14,105

 

$

11,683

 

$

48,938

 

$

11,419

 

$

11,348

 

$

12,320

 

$

11,206

 

$

46,294

                   
Consolidated Total

$

32,961

 

$

40,539

 

$

40,422

 

$

37,361

 

$

151,283

 

$

37,708

 

$

36,102

 

$

39,169

 

 

37,536

 

 

150,515

                   
*Q1 fiscal 2026 revenue by market has been revised from amount previously reported in our Q1 fiscal 2026 press release issued on June 5, 2025, to correct a classification error between market categories. Total Q1 fiscal sales were unaffected.
ASTRONOVA, INC.
Revenue by Type
(Unaudited, $ in thousands)
                     
Product ID Q1 FY25   Q2 FY25   Q3 FY25   Q4 FY25   FY 2025   Q1 FY26   Q2 FY26   Q3 FY26   Q4 FY26   FY 2026
Product ID HW

$

3,802

 

$

4,311

 

$

4,590

 

$

5,591

 

$

18,294

 

$

4,776

 

$

4,511

 

$

5,357

 

$

5,332

 

$

19,976

Product ID Recurring Supplies, Parts & Service

 

19,383

 

 

22,854

 

 

21,727

 

 

20,087

 

 

84,051

 

 

21,513

 

 

20,243

 

 

21,492

 

 

20,997

 

 

84,245

Total Product ID

$

23,185

 

$

27,165

 

$

26,317

 

$

25,678

 

$

102,345

 

$

26,289

 

$

24,754

 

$

26,849

 

$

26,330

 

$

104,221

Aerospace                  
Aerospace HW

$

5,073

 

$

8,048

 

$

7,032

 

$

6,185

 

$

26,338

 

$

6,519

 

$

6,425

 

$

7,360

 

$

6,369

 

$

26,673

Aerospace Recurring Supplies, Parts & Service

 

4,703

 

 

5,326

 

 

7,073

 

 

5,498

 

 

22,600

 

 

4,900

 

 

4,923

 

 

4,960

 

 

4,838

 

 

19,621

Total Aerospace

$

9,776

 

$

13,374

 

$

14,105

 

$

11,683

 

$

48,938

 

$

11,419

 

$

11,348

 

$

12,320

 

$

11,206

 

$

46,294

Consolidated                  
AstroNova HW

$

8,875

 

$

12,359

 

$

11,622

 

$

11,776

 

$

44,632

 

$

11,295

 

$

10,936

 

$

12,717

 

$

11,701

 

$

46,649

AstroNova Recurring Supplies, Parts & Service

 

24,086

 

 

28,180

 

 

28,800

 

 

25,585

 

 

106,651

 

 

26,413

 

 

25,166

 

 

26,452

 

 

25,835

 

 

103,866

TOTAL

$

32,961

 

$

40,539

 

$

40,422

 

$

37,361

 

$

151,283

 

$

37,708

 

$

36,102

 

$

39,169

 

$

37,536

 

$

150,515

ASTRONOVA, INC.
Bookings and Backlog
(Unaudited, $ in thousands)
   
AstroNova

Q1 FY25

Q2 FY25

Q3 FY25

Q4 FY25

FY 2025

Q1 FY26

Q2 FY26

Q3 FY26

Q4 FY26

FY 2026

Beginning backlog (Non-MTEX)

$

31,394

 

$

31,556

 

$

29,900

 

$

27,093

 

$

31,394

 

$

28,307

 

$

25,491

 

$

25,291

 

$

21,989

 

$

28,307

 

MTEX*

$

-

 

$

3,084

 

$

-

 

$

-

 

$

3,084

 

$

-

 

$

-

 

$

-

 

$

-

 

$

-

 

Backlog Beg. of Period (incl. MTEX)

$

31,394

 

$

34,640

 

$

29,900

 

$

27,093

 

$

34,478

 

$

28,307

 

$

25,491

 

$

25,291

 

$

21,989

 

$

28,307

 

Revenue Recognized (Billings)

$

32,961

 

$

40,539

 

$

40,422

 

$

37,361

 

$

151,283

 

$

37,708

 

$

36,102

 

$

39,169

 

$

37,536

 

$

150,515

 

New Bookings During Period

$

33,122

 

$

35,799

 

$

37,615

 

$

38,576

 

$

145,112

 

$

34,893

 

$

35,901

 

$

35,867

 

$

41,077

 

$

147,738

 

Backlog End of Period

$

31,556

 

$

29,900

 

$

27,093

 

$

28,307

 

$

28,307

 

$

25,491

 

$

25,291

 

$

21,989

 

$

25,530

 

$

25,530

 

Book/Bill %

 

100

%

 

88

%

 

93

%

 

103

%

 

96

%

 

93

%

 

99

%

 

92

%

 

109

%

 

96

%

*MTEX Backlog was acquired during 2nd quarter fiscal 2025
   
Product Identification

Q1 FY25

Q2 FY25

Q3 FY25

Q4 FY25

FY 2025

Q1 FY26

Q2 FY26

Q3 FY26

Q4 FY26

FY 2026

Beginning backlog (Non-MTEX)

$

19,725

 

$

19,467

 

$

18,786

 

$

19,254

 

$

19,725

 

$

18,091

 

$

18,044

 

$

16,727

 

$

12,351

 

$

18,091

 

MTEX*

$

-

 

$

3,084

 

$

-

 

$

-

 

$

3,084

 

$

-

 

$

-

 

$

-

 

$

-

 

$

-

 

Backlog Beg. of Period (incl. MTEX)

$

19,725

 

$

22,551

 

$

18,786

 

$

19,254

 

$

22,809

 

$

18,091

 

$

18,044

 

$

16,727

 

$

12,351

 

$

18,091

 

Revenue Recognized (Billings)

$

23,185

 

$

27,165

 

$

26,317

 

$

25,678

 

$

102,345

 

$

26,289

 

$

24,754

 

$

26,849

 

$

26,330

 

$

104,221

 

New Bookings During Period

$

22,926

 

$

23,400

 

$

26,785

 

$

24,516

 

$

97,627

 

$

26,242

 

$

23,437

 

$

22,473

 

$

27,460

 

$

99,612

 

Backlog End of Period

$

19,467

 

$

18,786

 

$

19,254

 

$

18,091

 

$

18,091

 

$

18,044

 

$

16,727

 

$

12,351

 

$

13,484

 

$

13,482

 

Book/Bill %

 

99

%

 

86

%

 

102

%

 

95

%

 

95

%

 

100

%

 

95

%

 

84

%

 

104

%

 

95

%

*MTEX Backlog was acquired during 2nd quarter fiscal 2025
   
Aerospace

Q1 FY25

Q2 FY25

Q3 FY25

Q4 FY25

FY 2025

Q1 FY26

Q2 FY26

Q3 FY26

Q4 FY26

FY 2025

Backlog Beginning of Period

$

11,669

 

$

12,089

 

$

11,114

 

$

7,839

 

$

11,669

 

$

10,216

 

$

7,447

 

$

8,563

 

$

9,638

 

$

10,216

 

Revenue Recognized (Billings)

$

9,776

 

$

13,374

 

$

14,105

 

$

11,683

 

$

48,938

 

$

11,419

 

$

11,348

 

$

12,320

 

$

11,206

 

$

46,294

 

New Bookings During Period

$

10,196

 

$

12,399

 

$

10,830

 

$

14,060

 

$

47,485

 

$

8,651

 

$

12,464

 

$

13,394

 

$

13,617

 

$

48,126

 

Backlog End of Period

$

12,089

 

$

11,114

 

$

7,839

 

$

10,216

 

$

10,216

 

$

7,447

 

$

8,563

 

$

9,638

 

$

12,047

 

$

12,048

 

Book/Bill %

 

104

%

 

93

%

 

77

%

 

120

%

 

97

%

 

76

%

 

110

%

 

109

%

 

122

%

 

97

%

ASTRONOVA, INC.

Segment Sales and Profit – Historical Quarterly Summary (Recast)

(unaudited, $ in thousands)

 
 
FY24 Q1 Q2 Q3 Q4 FY25 Q1 Q2 Q3 Q4 FY26
Aerospace Revenue

$

44,045

 

9,776

 

13,374

 

14,105

 

11,683

 

$

48,938

 

11,419

 

11,348

 

12,320

 

11,206

 

$

46,294

 

Gross profit

$

15,900

 

3,456

 

5,548

 

5,093

 

3,989

 

$

18,087

 

3,719

 

3,721

 

6,121

 

4,236

 

$

17,797

 

Gross Profit Margin

 

36.1

%

35.4

%

41.5

%

36.1

%

34.1

%

 

37.0

%

32.6

%

32.8

%

49.7

%

37.8

%

 

38.4

%

Operating Expenses:
Selling & Marketing

$

3,433

 

904

 

899

 

913

 

822

 

$

3,537

 

481

 

911

 

1,095

 

772

 

$

3,260

 

Research & Development

$

2,347

 

801

 

781

 

877

 

785

 

$

3,243

 

652

 

603

 

710

 

656

 

$

2,621

 

General & Administrative

$

1,881

 

644

 

567

 

512

 

497

 

$

2,220

 

606

 

540

 

536

 

471

 

$

2,154

 

Total Operating Expenses

$

7,661

 

2,348

 

2,246

 

2,301

 

2,104

 

$

9,000

 

1,739

 

2,055

 

2,341

 

1,899

 

$

8,034

 

 
Aerospace Operating Income

$

8,240

 

1,108

 

3,302

 

2,792

 

1,885

 

$

9,087

 

1,980

 

1,666

 

3,780

 

2,338

 

$

9,763

 

Aerospace Operating Margin

 

18.7

%

11.3

%

24.7

%

19.8

%

16.1

%

 

18.6

%

17.3

%

14.7

%

30.7

%

20.9

%

 

21.1

%

Non-GAAP
Aerospace Adjusted EBITDA1

$

10,239

 

1,519

 

3,719

 

3,193

 

2,279

 

$

10,710

 

2,566

 

2,081

 

3,911

 

3,104

 

$

11,662

 

Adjusted EBITDA Margin1

 

23.2

%

15.5

%

27.8

%

22.6

%

19.5

%

 

21.9

%

22.5

%

18.3

%

31.7

%

27.7

%

 

25.2

%

   
FY24 Q1 Q2 Q3 Q4 FY25 Q1 Q2 Q3 Q4 FY26
Product ID Revenue

$

104,041

 

23,185

 

27,165

 

26,317

 

25,679

 

$

102,345

 

26,289

 

24,754

 

26,849

 

26,330

 

$

104,221

 

Gross profit

$

33,604

 

8,002

 

8,315

 

8,015

 

8,236

 

$

32,570

 

8,232

 

7,194

 

7,323

 

7,088

 

$

29,838

 

Gross Profit Margin

 

32.3

%

34.5

%

30.6

%

30.5

%

32.1

%

 

31.8

%

31.3

%

29.1

%

27.3

%

26.9

%

 

28.6

%

Operating Expenses:
Selling & Marketing

$

19,971

 

4,436

 

5,567

 

5,438

 

5,274

 

$

20,715

 

5,124

 

4,935

 

4,773

 

4,870

 

$

19,703

 

Research & Development

$

3,994

 

670

 

507

 

795

 

832

 

$

2,804

 

877

 

961

 

1,188

 

1,141

 

$

4,167

 

General & Administrative

$

4,314

 

1,447

 

2,363

 

1,896

 

15,206

 

$

20,911

 

1,971

 

1,490

 

1,667

 

1,310

 

$

6,439

 

Total Operating Expenses

$

28,280

 

6,553

 

8,437

 

8,128

 

21,312

 

$

44,430

 

7,973

 

7,387

 

7,628

 

7,323

 

$

30,310

 

 
Product ID Operating Income

$

5,325

 

1,449

 

(121

)

(112

)

(13,076

)

$

(11,860

)

259

 

(192

)

(304

)

(234

)

$

(472

)

Product ID Operating Margin

 

5.1

%

6.2

%

-0.4

%

-0.4

%

-50.9

%

 

-11.6

%

1.0

%

-0.8

%

-1.1

%

-0.9

%

 

-0.5

%

Non-GAAP
Product ID Adjusted EBITDA1

$

11,156

 

2,046

 

1,619

 

1,269

 

1,615

 

$

6,550

 

1,902

 

870

 

1,371

 

1,095

 

$

5,238

 

Adjusted EBITDA Margin1

 

10.7

%

8.8

%

6.0

%

4.8

%

6.3

%

 

6.4

%

7.2

%

3.5

%

5.1

%

4.2

%

 

5.0

%

   
Corporate Expense

$

4,768

 

1,211

 

2,120

 

1,416

 

1,120

 

$

5,867

 

1,668

 

2,181

 

2,187

 

2,049

 

$

8,086

 

   
Consolidated Consolidated Operating Income

 

8,796

 

1,346

 

1,061

 

1,264

 

(12,311

)

 

(8,640

)

571

 

(708

)

1,288

 

55

 

 

1,206

 

Consolidated Operating Margin

 

5.9

%

4.1

%

2.6

%

3.1

%

-33.0

%

 

-5.7

%

1.5

%

-2.0

%

3.3

%

0.1

%

 

0.8

%

Non-GAAP
Adjusted EBITDA1

$

17,601

 

2,463

 

3,849

 

3,230

 

2,793

 

$

12,336

 

3,146

 

2,056

 

4,173

 

3,306

 

$

12,681

 

Adjusted EBITDA Margin1

 

11.9

%

7.5

%

9.5

%

8.0

%

7.5

%

 

8.2

%

8.3

%

5.7

%

10.7

%

8.8

%

 

8.4

%

   
 

1Adjusted EBITDA and Adjusted EBITDA margin are non-GAAP metrics. Please refer to the reconciliation of GAAP to non-GAAP metrics in the tables that accompany this news release.

ASTRONOVA, INC.
Reconciliation of GAAP to Non-GAAP Items

(Unaudited, $ in thousands)

  

Three Months Ended Twelve Months Ended 2H Fiscal 2026 and 1H Fiscal 2026
January 31,
2026
January 31,
2025
January 31,
2026
January 31,
2025
2H FY26 1H FY26
 
Revenue

$

37,536

 

$

37,361

 

$

150,515

 

$

151,283

 

$

76,705

 

$

73,810

 

   
Gross Profit

$

11,324

 

$

12,227

 

$

47,634

 

$

50,658

 

$

24,769

 

$

22,866

 

Inventory Step-Up

 

-

 

 

62

 

 

61

 

 

216

 

 

-

 

 

61

 

Inventory Provision

 

365

 

 

-

 

 

724

 

 

-

 

 

724

 

Restructuring Charges

 

29

 

 

-

 

 

367

 

 

-

 

 

30

 

 

337

 

Product Retrofit Costs

 

185

 

 

-

 

 

185

 

 

-

 

 

185

 

Non-GAAP Gross Profit

$

11,903

 

$

12,289

 

$

48,971

 

$

50,874

 

$

25,708

 

$

23,264

 

Gross Profit Margin

 

30.2

%

 

32.7

%

 

31.6

%

 

33.5

%

 

32.3

%

 

31.0

%

Non-GAAP Gross Profit Margin

 

31.7

%

 

32.9

%

 

32.5

%

 

33.6

%

 

33.5

%

 

31.5

%

   
Operating Expenses

$

11,270

 

$

24,538

 

$

46,428

 

$

59,298

 

$

23,426

 

$

23,003

 

MTEX-related Acquisition Expenses

 

-

 

 

(254

)

 

(311

)

 

(1,204

)

 

-

 

 

(311

)

CFO Transition Costs

 

-

 

 

-

 

 

-

 

 

(432

)

 

-

 

 

-

 

Restructuring Charges

 

(23

)

 

-

 

 

(990

)

 

-

 

 

(81

)

 

(910

)

Non-Recurring Legal Expenses

 

(258

)

 

-

 

 

(715

)

 

-

 

 

(646

)

 

(69

)

Non-Recurring Proxy Costs

 

(210

)

 

-

 

 

(738

)

 

-

 

 

(383

)

 

(355

)

Goodwill Impairment

 

-

 

 

(13,403

)

 

(297

)

 

(13,403

)

 

(297

)

Non-GAAP Operating Expenses

$

10,779

 

$

10,881

 

$

43,377

 

$

44,259

 

$

22,019

 

$

21,358

 

   
Operating Income (Loss)

$

54

 

$

(12,311

)

$

1,206

 

$

(8,640

)

$

1,342

 

$

(137

)

MTEX-related Acquisition Expenses

 

-

 

 

254

 

 

311

 

 

1,204

 

 

-

 

 

311

 

CFO Transition Costs

 

-

 

 

-

 

 

-

 

 

432

 

 

-

 

 

-

 

Inventory Step-Up

 

-

 

 

62

 

 

61

 

 

216

 

 

-

 

 

61

 

Inventory Provision

 

365

 

 

-

 

 

724

 

 

-

 

 

724

 

Restructuring Charges

 

52

 

 

-

 

 

1,357

 

 

-

 

 

110

 

 

1,247

 

Product Retrofit Costs

 

185

 

 

-

 

 

185

 

 

-

 

 

186

 

Non-Recurring Legal Expenses

 

258

 

 

-

 

 

715

 

 

-

 

 

646

 

 

69

 

Non-Recurring Proxy Costs

 

210

 

 

-

 

 

738

 

 

-

 

 

383

 

 

355

 

Goodwill Impairment

 

-

 

 

13,403

 

 

297

 

 

13,403

 

 

297

 

Non-GAAP Operating Income

$

1,124

 

$

1,408

 

$

5,594

 

$

6,615

 

$

3,688

 

$

1,906

 

Operating Income Margin

 

0.1

%

 

-33.0

%

 

0.8

%

 

-5.7

%

 

1.7

%

 

-0.2

%

Non-GAAP Operating Income Margin

 

3.0

%

 

3.8

%

 

3.7

%

 

4.4

%

 

4.8

%

 

2.6

%

   
Net Income (Loss)

$

(1,134

)

$

(15,600

)

$

(2,376

)

$

(14,489

)

$

(756

)

$

(1,620

)

MTEX-related Acquisition Expenses(1)

 

-

 

 

197

 

 

237

 

 

910

 

 

-

 

 

237

 

CFO Transition Costs, net(1)

 

-

 

 

(4

)

 

-

 

 

328

 

 

-

 

 

-

 

Inventory Step-Up(1)

 

-

 

 

50

 

 

49

 

 

161

 

 

-

 

 

49

 

Inventory Provision(1)

 

292

 

 

-

 

 

565

 

 

-

 

 

565

 

 

-

 

Restructuring Charges(1)

 

41

 

 

-

 

 

1,030

 

 

-

 

 

80

 

 

950

 

Product Retrofit Costs(1)

 

148

 

 

-

 

 

148

 

 

-

 

 

148

 

 

-

 

Non-Recurring Legal Expenses(1)

 

189

 

 

-

 

 

542

 

 

-

 

 

489

 

 

53

 

Non-Recurring Proxy Costs(1)

 

160

 

 

-

 

 

561

 

 

-

 

 

289

 

 

272

 

Realized Fx(1)

 

-

 

 

-

 

 

80

 

 

-

 

 

80

 

 

-

 

Other (Income) and Expense(1)

 

-

 

 

-

 

 

85

 

 

-

 

 

85

 

 

-

 

Goodwill Impairment

 

-

 

 

13,403

 

 

297

 

 

13,403

 

 

297

 

 

-

 

Tax Provision Valuation Allowance

 

-

 

 

2,373

 

 

-

 

 

2,373

 

 

-

 

 

-

 

Non-GAAP Net Income (Loss)

$

(305

)

$

419

 

$

1,218

 

$

2,686

 

$

1,277

 

$

(59

)

   
Diluted Earnings (Loss) Per Share

$

(0.15

)

$

(2.07

)

$

(0.31

)

$

(1.93

)

$

(0.10

)

$

(0.21

)

MTEX-related Acquisition Expenses(1)

 

-

 

 

0.03

 

 

0.03

 

 

0.12

 

 

-

 

 

0.03

 

CFO Transition Costs, net(1)

 

-

 

 

(0.00

)

 

-

 

 

0.04

 

 

-

 

 

-

 

Inventory Step-Up(1)

 

-

 

 

0.01

 

 

0.01

 

 

0.02

 

 

-

 

 

0.01

 

Inventory Provision(1)

 

0.04

 

 

-

 

 

0.07

 

 

-

 

 

0.07

 

 

-

 

Restructuring Charges(1)

 

0.01

 

 

-

 

 

0.14

 

 

-

 

 

0.01

 

 

0.13

 

Product Retrofit Costs(1)

 

0.02

 

 

-

 

 

0.02

 

 

-

 

 

0.02

 

 

-

 

Non-Recurring Legal Expenses(1)

 

0.02

 

 

-

 

 

0.07

 

 

-

 

 

0.06

 

 

0.01

 

Non-Recurring Proxy Costs(1)

 

0.02

 

 

-

 

 

0.07

 

 

-

 

 

0.04

 

 

0.04

 

Realized Fx(1)

 

-

 

 

-

 

 

0.01

 

 

-

 

 

0.01

 

 

-

 

Other (Income) and Expense(1)

 

-

 

 

-

 

 

0.01

 

 

-

 

 

0.01

 

 

-

 

Goodwill Impairment(1)

 

-

 

 

1.78

 

 

0.04

 

 

1.76

 

 

0.04

 

 

-

 

Tax Provision Valuation Allowance

 

-

 

 

0.31

 

 

-

 

 

0.31

 

 

-

 

 

-

 

Non-GAAP Diluted Earnings (Loss) Per Share

$

(0.04

)

$

0.06

 

$

0.16

 

$

0.32

 

$

0.16

 

$

(0.01

)

    
(1) Net of taxes

ASTRONOVA, INC.

Reconciliation of Net Income and Margin to Adjusted EBITDA and Margin

(Unaudited, $ in thousands)

   
Three Months Ended
January 31,
2026
January 31,
2025
   
Net Income (Loss)

$

(1,134

)

$

(15,600

)

Interest Expense

 

894

 

 

847

 

Income Tax Expense (Benefit)

 

346

 

 

2,342

 

Depreciation & Amortization

 

1,379

 

 

1,266

 

EBITDA

$

1,485

 

$

(11,145

)

Share-Based Compensation

 

752

 

 

219

 

MTEX-related Acquisition Expenses

 

-

 

 

259

 

CFO Transition Costs

 

-

 

 

(5

)

Inventory Step-Up

 

-

 

 

62

 

Inventory Provision

 

365

 

 

-

 

Restructuring Charges

 

52

 

 

-

 

Product Retrofit Costs

 

185

 

 

-

 

Non-Recurring Legal Expenses

 

258

 

 

-

 

Non-Recurring Proxy Costs

 

210

 

 

-

 

Goodwill Impairment

 

-

 

 

13,403

 

Adjusted EBITDA

$

3,306

 

$

2,794

 

Revenue

$

37,536

 

$

37,361

 

Net Income (Loss) Margin

 

(3.0

)%

 

(41.8

)%

Adjusted EBITDA Margin

 

8.8

%

 

7.5

%

   
Twelve Months Ended 2H Fiscal 2026 and 1H 2026
January 31,
2026
January 31,
2025
2H FY26 1H FY26
   
Net Income (Loss)

$

(2,376

)

$

(14,489

)

$

(757

)

$

(1,619

)

Interest Expense

 

3,503

 

 

3,210

 

 

1,721

 

 

1,782

 

Income Tax Expense (Benefit)

 

(160

)

 

2,202

 

 

218

 

 

(378

)

Depreciation & Amortization

 

4,804

 

 

4,780

 

 

2,234

 

 

2,570

 

EBITDA

$

5,771

 

$

(4,297

)

$

3,418

 

$

2,355

 

Share-Based Compensation

 

2,310

 

 

1,378

 

 

1,505

 

 

805

 

MTEX-related Acquisition Expenses

 

311

 

 

1,204

 

 

-

 

 

311

 

CFO Transition Costs

 

-

 

 

432

 

 

-

 

 

-

 

Inventory Step-Up

 

61

 

 

216

 

 

-

 

 

61

 

Inventory Provision

 

724

 

 

-

 

 

724

 

 

-

 

Restructuring Charges

 

1,357

 

 

-

 

 

110

 

 

1,247

 

Product Retrofit Costs

 

185

 

 

-

 

 

185

 

 

-

 

Non-Recurring Legal Expenses

 

715

 

 

-

 

 

646

 

 

69

 

Non-Recurring Proxy Costs

 

738

 

 

-

 

 

383

 

 

355

 

Realized Fx

 

100

 

 

-

 

 

100

 

 

-

 

Other (Income) and Expense

 

112

 

 

-

 

 

112

 

 

-

 

Goodwill Impairment

 

297

 

 

13,403

 

 

297

 

 

-

 

Adjusted EBITDA

$

12,681

 

$

12,336

 

$

7,478

 

$

5,203

 

Revenue

$

150,515

 

$

151,283

 

$

76,705

 

$

73,810

 

Net Income (Loss) Margin

 

(1.6

)%

 

(9.6

)%

 

(1.0

)%

 

(2.2

)%

Adjusted EBITDA Margin

 

8.4

%

 

8.2

%

 

9.7

%

 

7.0

%

ASTRONOVA, INC.

Reconciliation of Segment Gross Profit and Margin to Non-GAAP Gross Profit and Margin

(Unaudited, $ in thousands)

  

Three Months Ended
January 31, 2026 January 31, 2025
Product
ID
Aerospace Total Product
ID
Aerospace Total
 
Segment Gross Profit

$

7,088

 

$

4,237

 

$

11,325

 

$

8,237

 

$

3,989

 

$

12,226

 

 
Inventory Step-Up

 

-

 

 

-

 

 

-

 

 

62

 

 

-

 

 

62

 

 
Inventory Provision

 

54

 

 

311

 

 

365

 

 

-

 

 

-

 

 

-

 

 
Product Retrofit Costs

 

185

 

 

-

 

 

185

 

 

-

 

 

-

 

 

-

 

 
Restructuring Charges

 

29

 

 

-

 

 

29

 

 

-

 

 

-

 

 

-

 

   
Non-GAAP - Segment Gross Profit

$

7,356

 

$

4,548

 

$

11,904

 

$

8,299

 

$

3,989

 

$

12,288

 

   
Revenue

$

26,330

 

$

11,206

 

$

37,536

 

$

25,678

 

$

11,683

 

$

37,361

 

Gross Profit Margin

 

26.9

%

 

37.8

%

 

30.2

%

 

32.1

%

 

34.1

%

 

32.7

%

Non-GAAP Segment Gross Profit Margin

 

27.9

%

 

40.6

%

 

31.7

%

 

32.3

%

 

34.1

%

 

32.9

%

   
   
Twelve Months Ended
January 31, 2026 January 31, 2025
Product
ID
Aerospace Total Product
ID
Aerospace Total
   
Segment Gross Profit

$

29,837

 

$

17,797

 

$

47,634

 

$

32,571

 

$

18,087

 

$

50,658

 

   
Inventory Step-Up

 

61

 

 

-

 

 

61

 

 

216

 

 

-

 

 

216

 

   
Inventory Provision

 

724

 

 

-

 

 

724

 

 

-

 

 

-

 

 

-

 

   
Product Retrofit Costs

 

185

 

 

-

 

 

185

 

 

-

 

 

-

 

 

-

 

   
Restructuring Charges

 

202

 

 

165

 

 

367

 

 

-

 

 

-

 

 

-

 

   
Non-GAAP - Segment Gross Profit

$

31,009

 

$

17,962

 

$

48,971

 

$

32,787

 

$

18,087

 

$

50,874

 

   
Revenue

$

104,221

 

$

46,294

 

$

150,515

 

$

102,345

 

$

48,938

 

$

151,283

 

Gross Profit Margin

 

28.6

%

 

38.4

%

 

31.6

%

 

31.8

%

 

37.0

%

 

33.5

%

Non-GAAP Segment Gross Profit Margin

 

29.8

%

 

38.8

%

 

32.5

%

 

32.0

%

 

37.0

%

 

33.6

%

ASTRONOVA, INC.

Reconciliation of Segment Operating Profit and Margin to Non-GAAP Operating Profit and Margin

(Unaudited, $ in thousands)

 

Three Months Ended
January 31, 2026 January 31, 2025
Product
ID
Aerospace Total Product
ID
Aerospace Total
   
Segment Operating Income (Loss)

$

(234

)

$

2,337

 

$

2,103

 

$

(13,075

)

$

1,886

 

$

(11,189

)

   
MTEX-related Acquisition Expenses

 

-

 

 

-

 

 

-

 

 

259

 

 

-

 

 

259

 

   
Inventory Step-Up

 

-

 

 

-

 

 

-

 

 

62

 

 

-

 

 

62

 

   
Inventory Provision

 

54

 

 

311

 

 

365

 

 

-

 

 

-

 

 

-

 

   
Product Retrofit Costs

 

185

 

 

-

 

 

185

 

 

-

 

 

-

 

 

-

 

   
Restructuring Charges

 

52

 

 

-

 

 

52

 

 

-

 

 

-

 

 

-

 

   
Non-Recurring Legal Expenses

 

(181

)

 

-

 

 

(181

)

 

-

 

 

-

 

 

-

 

   
Goodwill Impairment

 

-

 

 

-

 

 

-

 

 

13,403

 

 

-

 

 

13,403

 

Non-GAAP - Segment Operating Income (Loss)

$

(124

)

$

2,648

 

$

2,524

 

$

649

 

$

1,886

 

$

2,535

 

   
Revenue

$

26,330

 

$

11,206

 

$

37,536

 

$

25,678

 

$

11,683

 

$

37,361

 

Operating Margin

 

-0.9

%

 

20.9

%

 

5.6

%

 

-50.9

%

 

16.1

%

 

-29.9

%

Non-GAAP Operating Margin

 

-0.5

%

 

23.6

%

 

6.7

%

 

2.5

%

 

16.1

%

 

6.8

%

   
   
Twelve Months Ended
January 31, 2026 January 31, 2025
Product
ID
Aerospace Total Product
ID
Aerospace Total
   
Segment Operating Income (Loss)

$

(471

)

$

9,763

 

$

9,292

 

$

(11,860

)

$

9,088

 

$

(2,772

)

   
MTEX-related Acquisition Expenses

 

311

 

 

-

 

 

311

 

 

1,204

 

 

-

 

 

1,204

 

   
Inventory Step-Up

 

61

 

 

-

 

 

61

 

 

216

 

 

-

 

 

216

 

   
Inventory Provision

 

724

 

 

-

 

 

724

 

 

-

 

 

-

 

 

-

 

   
Product Retrofit Costs

 

185

 

 

-

 

 

185

 

 

-

 

 

-

 

 

-

 

   
Restructuring Charges

 

483

 

 

171

 

 

654

 

 

-

 

 

-

 

 

-

 

 

 

-

 

Non-Recurring Legal Expenses

 

(48

)

 

-

 

 

(48

)

 

-

 

 

-

 

   
Goodwill Impairment

 

297

 

 

-

 

 

297

 

 

13,403

 

 

-

 

 

13,403

 

Non-GAAP - Segment Operating Income

$

1,542

 

$

9,934

 

$

11,476

 

$

2,963

 

$

9,088

 

$

12,051

 

   
Revenue

$

104,221

 

$

46,294

 

$

150,515

 

$

102,345

 

$

48,938

 

$

151,283

 

Operating Margin

 

-0.5

%

 

21.1

%

 

6.2

%

 

-11.6

%

 

18.6

%

 

-1.8

%

Non-GAAP Operating Margin

 

1.5

%

 

21.5

%

 

7.6

%

 

2.9

%

 

18.6

%

 

8.0

%

ASTRONOVA INC.

Reconciliation of Segment and Consolidated Net Income to Adjusted EBITDA (Past Quarters and Years)

(Unaudited, $ in thousands)

 

 

2024

 

 

Q1 25

Q2 25

Q3 25

Q4 25

FY25

 

Q1 26

Q2 26

Q3 26

Q4 26

FY26

Aerospace

Operating Income

$

8,240

 

$

1,108

 

$

3,302

 

$

2,792

 

$

1,886

 

$

9,088

 

$

1,980

 

$

1,666

 

$

3,780

 

$

2,338

 

$

9,763

 

Other

 

-

 

 

-

 

 

-

 

 

-

 

 

-

 

 

-

 

 

-

 

 

-

 

 

-

 

 

-

 

 

-

 

Interest expense

 

-

 

 

-

 

 

-

 

 

-

 

 

-

 

 

-

 

 

-

 

 

-

 

 

-

 

 

-

 

 

-

 

Profit Before Tax

$

8,240

 

 

1,108

 

 

3,302

 

 

2,792

 

 

1,886

 

$

9,088

 

 

1,980

 

 

1,666

 

 

3,780

 

 

2,338

 

$

9,763

 

Tax

 

-

 

 

-

 

 

-

 

 

-

 

 

-

 

 

-

 

 

-

 

 

-

 

 

-

 

 

-

 

 

-

 

Net Income

$

8,240

 

 

1,108

 

 

3,302

 

 

2,792

 

 

1,886

 

$

9,088

 

 

1,980

 

 

1,666

 

 

3,780

 

 

2,338

 

$

9,763

 

Depreciation & Amortization

 

1,873

 

 

374

 

 

378

 

 

365

 

 

365

 

 

1,482

 

 

373

 

 

368

 

 

363

 

 

360

 

 

1,464

 

Share-Based Compensation

 

126

 

 

37

 

 

39

 

 

36

 

 

29

 

 

140

 

 

43

 

 

46

 

 

80

 

 

94

 

 

263

 

Inventory Provision

 

-

 

 

-

 

 

-

 

 

-

 

 

-

 

 

-

 

 

-

 

 

-

 

 

(311

)

 

311

 

 

-

 

Restructuring Charges

 

-

 

 

-

 

 

-

 

 

-

 

 

-

 

 

-

 

 

170

 

 

1

 

 

-

 

 

-

 

 

171

 

Adjusted EBITDA

$

10,239

 

$

1,519

 

$

3,719

 

$

3,193

 

$

2,279

 

$

10,710

 

$

2,566

 

$

2,081

 

$

3,911

 

$

3,104

 

$

11,662

 

Revenue

$

44,045

 

$

9,776

 

$

13,374

 

$

14,105

 

$

11,683

 

$

48,938

 

$

11,419

 

$

11,348

 

$

12,320

 

$

11,206

 

$

46,294

 

Adjusted EBITDA Margin

 

23.2

%

 

15.5

%

 

27.8

%

 

22.6

%

 

19.5

%

 

21.9

%

 

22.5

%

 

18.3

%

 

31.7

%

 

27.7

%

 

25.2

%

   
 

 

2024

 

 

Q1 25

Q2 25

Q3 25

Q4 25

FY25

 

Q1 26

Q2 26

Q3 26

Q4 26

FY26

   
Product ID Operating Income

$

5,325

 

$

1,449

 

$

(121

)

$

(113

)

$

(13,075

)

$

(11,860

)

$

259

 

$

(192

)

$

(304

)

$

(234

)

$

(471

)

Other

 

-

 

 

-

 

 

-

 

 

-

 

 

-

 

 

-

 

 

-

 

 

-

 

 

-

 

 

-

 

 

-

 

Interest expense

 

-

 

 

-

 

 

-

 

 

-

 

 

-

 

 

-

 

 

-

 

 

-

 

 

-

 

 

-

 

 

-

 

Profit Before Tax

$

5,325

 

 

1,449

 

 

(121

)

 

(113

)

 

(13,075

)

$

(11,860

)

 

259

 

 

(192

)

 

(304

)

 

(234

)

$

(471

)

Tax

 

-

 

 

-

 

 

-

 

 

-

 

 

-

 

 

-

 

 

-

 

 

-

 

 

-

 

 

-

 

 

-

 

Net Income

$

5,325

 

 

1,449

 

 

(121

)

 

(113

)

 

(13,075

)

$

(11,860

)

 

259

 

 

(192

)

 

(304

)

 

(234

)

$

(471

)

Interest expense

 

-

 

 

-

 

 

-

 

 

-

 

 

-

 

 

-

 

 

-

 

 

-

 

 

-

 

 

-

 

 

-

 

Tax

 

-

 

 

-

 

 

-

 

 

-

 

 

-

 

 

-

 

 

-

 

 

-

 

 

-

 

 

-

 

 

-

 

Depreciation & Amortization

 

2,378

 

 

532

 

 

921

 

 

929

 

 

896

 

 

3,279

 

 

913

 

 

909

 

 

489

 

 

1,013

 

 

3,322

 

Share-Based Compensation

 

317

 

 

64

 

 

74

 

 

94

 

 

75

 

 

308

 

 

(7

)

 

86

 

 

88

 

 

207

 

 

373

 

MTEX-related Acquisition Expenses

 

-

 

 

-

 

 

625

 

 

325

 

 

254

 

 

1,204

 

 

337

 

 

(26

)

 

-

 

 

-

 

 

311

 

Inventory Step-Up

 

-

 

 

-

 

 

120

 

 

34

 

 

62

 

 

216

 

 

61

 

 

-

 

 

-

 

 

-

 

 

61

 

Inventory Provision

 

-

 

 

-

 

 

-

 

 

-

 

 

-

 

 

-

 

 

-

 

 

-

 

 

670

 

 

54

 

 

724

 

Restructuring Charges

 

2,494

 

 

-

 

 

-

 

 

-

 

 

-

 

 

-

 

 

339

 

 

94

 

 

(2

)

 

52

 

 

483

 

Product Retrofit Costs

 

642

 

 

-

 

 

-

 

 

-

 

 

-

 

 

-

 

 

-

 

 

-

 

 

-

 

 

185

 

 

185

 

Non-Recurring Legal Expenses

 

-

 

 

-

 

 

-

 

 

-

 

 

-

 

 

-

 

 

-

 

 

-

 

 

134

 

 

(182

)

 

(48

)

Goodwill Impairment

 

-

 

 

-

 

 

-

 

 

-

 

 

13,403

 

 

13,403

 

 

-

 

 

-

 

 

297

 

 

-

 

 

297

 

Adjusted EBITDA

$

11,156

 

$

2,046

 

$

1,619

 

$

1,269

 

$

1,615

 

$

6,550

 

$

1,902

 

$

870

 

$

1,371

 

$

1,095

 

$

5,238

 

Revenue

$

104,041

 

$

23,185

 

$

27,165

 

$

26,317

 

$

25,679

 

$

102,345

 

$

26,289

 

$

24,754

 

$

26,849

 

$

26,330

 

$

104,221

 

Adjusted EBITDA Margin

 

10.7

%

 

8.8

%

 

6.0

%

 

4.8

%

 

6.3

%

 

6.4

%

 

7.2

%

 

3.5

%

 

5.1

%

 

4.2

%

 

5.0

%

   
 

 

2024

 

 

Q1 25

Q2 25

Q3 25

Q4 25

FY25

 

Q1 26

Q2 26

Q3 26

Q4 26

FY26

   
Corporate Operating Income

$

(4,768

)

$

(1,211

)

$

(2,120

)

$

(1,416

)

$

(1,122

)

$

(5,869

)

$

(1,668

)

$

(2,181

)

$

(2,187

)

$

(2,050

)

$

(8,087

)

Other

 

26

 

 

118

 

 

173

 

 

46

 

 

100

 

 

437

 

 

(24

)

 

104

 

 

210

 

 

(51

)

 

239

 

Interest expense

 

2,697

 

 

482

 

 

938

 

 

944

 

 

847

 

 

3,210

 

 

897

 

 

885

 

 

827

 

 

894

 

 

3,503

 

Profit Before Tax

$

(7,491

)

 

(1,811

)

 

(3,231

)

 

(2,406

)

 

(2,069

)

$

(9,516

)

 

(2,541

)

 

(3,170

)

 

(3,224

)

 

(2,893

)

$

(11,829

)

Tax

 

1,379

 

 

(434

)

 

261

 

 

34

 

 

2,342

 

 

2,203

 

 

75

 

 

(454

)

 

(128

)

 

346

 

 

(161

)

Net Income

$

(8,870

)

 

(1,377

)

 

(3,492

)

 

(2,440

)

 

(4,411

)

$

(11,719

)

 

(2,616

)

 

(2,716

)

 

(3,096

)

 

(3,239

)

$

(11,668

)

Interest expense

 

2,697

 

 

482

 

 

938

 

 

944

 

 

847

 

 

3,210

 

 

897

 

 

885

 

 

827

 

 

894

 

 

3,503

 

Tax

 

1,379

 

 

(434

)

 

261

 

 

36

 

 

2,342

 

 

2,205

 

 

75

 

 

(454

)

 

(128

)

 

346

 

 

(161

)

Depreciation & Amortization

 

15

 

 

4

 

 

4

 

 

6

 

 

4

 

 

19

 

 

4

 

 

4

 

 

5

 

 

5

 

 

18

 

EBITDA

$

(4,779

)

 

(1,324

)

 

(2,289

)

 

(1,454

)

 

(1,218

)

$

(6,285

)

 

(1,640

)

 

(2,282

)

 

(2,392

)

 

(1,994

)

$

(8,308

)

 
Share-Based Compensation

 

903

 

 

223

 

 

368

 

 

222

 

 

116

 

 

929

 

 

270

 

 

367

 

 

586

 

 

449

 

 

1,673

 

CFO Transition Costs

 

-

 

 

-

 

 

432

 

 

-

 

 

-

 

 

432

 

 

-

 

 

-

 

 

-

 

 

-

 

 

-

 

Restructuring Charges

 

82

 

 

-

 

 

-

 

 

-

 

 

-

 

 

-

 

 

49

 

 

595

 

 

60

 

 

-

 

 

703

 

Non-Recurring Legal Expenses

 

-

 

 

-

 

 

-

 

 

-

 

 

-

 

 

-

 

 

-

 

 

69

 

 

254

 

 

440

 

 

763

 

Non-Recurring Proxy Costs

 

-

 

 

-

 

 

-

 

 

-

 

 

-

 

 

-

 

 

-

 

 

355

 

 

172

 

 

210

 

 

738

 

Realized Fx

 

-

 

 

-

 

 

-

 

 

-

 

 

-

 

 

-

 

 

-

 

 

-

 

 

100

 

 

-

 

 

100

 

Other (Income) and Expense

 

-

 

 

-

 

 

-

 

 

-

 

 

-

 

 

-

 

 

-

 

 

-

 

 

112

 

 

-

 

 

112

 

Adjusted EBITDA

$

(3,794

)

$

(1,101

)

$

(1,489

)

$

(1,232

)

$

(1,102

)

$

(4,924

)

$

(1,321

)

$

(896

)

$

(1,108

)

$

(895

)

$

(4,220

)

   
 

 

2024

 

 

Q1 25

Q2 25

Q3 25

Q4 25

FY25

 

Q1 26

Q2 26

Q3 26

Q4 26

FY26

   
AstroNova Consolidated Operating Income

$

8,796

 

$

1,346

 

$

1,061

 

$

1,263

 

$

(12,311

)

$

(8,641

)

$

571

 

$

(708

)

$

1,288

 

$

55

 

$

1,207

 

Other

 

26

 

 

118

 

 

173

 

 

46

 

 

100

 

 

437

 

 

(24

)

 

104

 

 

210

 

 

(51

)

 

239

 

Interest expense

 

2,697

 

 

482

 

 

938

 

 

944

 

 

847

 

 

3,210

 

 

897

 

 

885

 

 

827

 

 

894

 

 

3,503

 

Profit Before Tax

$

6,073

 

 

746

 

 

(50

)

 

273

 

 

(13,258

)

$

(12,288

)

 

(302

)

 

(1,697

)

 

251

 

 

(789

)

$

(2,536

)

Tax

 

1,379

 

 

(434

)

 

261

 

 

34

 

 

2,342

 

 

2,202

 

 

75

 

 

(454

)

 

(128

)

 

346

 

 

(161

)

Net Income

$

4,694

 

 

1,180

 

 

(311

)

 

239

 

 

(15,600

)

$

(14,490

)

 

(377

)

 

(1,243

)

 

379

 

 

(1,134

)

$

(2,374

)

Interest expense

 

2,697

 

 

482

 

 

938

 

 

944

 

 

847

 

 

3,210

 

 

897

 

 

885

 

 

827

 

 

894

 

 

3,503

 

Tax

 

1,379

 

 

(434

)

 

261

 

 

36

 

 

2,342

 

 

2,202

 

 

75

 

 

(454

)

 

(128

)

 

346

 

 

(161

)

Depreciation & Amortization

 

4,266

 

 

911

 

 

1,304

 

 

1,300

 

 

1,266

 

 

4,780

 

 

1,290

 

 

1,280

 

 

856

 

 

1,379

 

 

4,805

 

EBITDA

$

13,036

 

 

2,139

 

 

2,191

 

 

2,519

 

 

(11,146

)

$

(4,297

)

 

1,885

 

 

469

 

 

1,934

 

 

1,485

 

$

5,773

 

 
Share-Based Compensation

 

1,347

 

 

325

 

 

481

 

 

352

 

 

219

 

 

1,378

 

 

306

 

 

499

 

 

754

 

 

751

 

 

2,310

 

MTEX-related Acquisition Expenses

 

-

 

 

-

 

 

625

 

 

325

 

 

254

 

 

1,204

 

 

337

 

 

(26

)

 

-

 

 

-

 

 

311

 

CFO Transition Costs

 

-

 

 

-

 

 

432

 

 

-

 

 

-

 

 

432

 

 

-

 

 

-

 

 

-

 

 

-

 

 

-

 

Inventory Step-Up

 

-

 

 

-

 

 

120

 

 

34

 

 

62

 

 

216

 

 

61

 

 

-

 

 

-

 

 

-

 

 

61

 

Inventory Provision

 

-

 

 

-

 

 

-

 

 

-

 

 

-

 

 

-

 

 

-

 

 

-

 

 

359

 

 

365

 

 

724

 

Restructuring Charges

 

2,576

 

 

-

 

 

-

 

 

-

 

 

-

 

 

-

 

 

558

 

 

689

 

 

59

 

 

52

 

 

1,357

 

Product Retrofit Costs

 

642

 

 

-

 

 

-

 

 

-

 

 

-

 

 

-

 

 

-

 

 

-

 

 

-

 

 

185

 

 

185

 

Non-Recurring Legal Expenses

 

-

 

 

-

 

 

-

 

 

-

 

 

-

 

 

-

 

 

-

 

 

69

 

 

387

 

 

258

 

 

715

 

Non-Recurring Proxy Costs

 

-

 

 

-

 

 

-

 

 

-

 

 

-

 

 

-

 

 

-

 

 

355

 

 

172

 

 

210

 

 

738

 

Realized Fx

 

-

 

 

-

 

 

-

 

 

-

 

 

-

 

 

-

 

 

-

 

 

-

 

 

100

 

 

-

 

 

100

 

Other (Income) and Expense

 

-

 

 

-

 

 

-

 

 

-

 

 

-

 

 

-

 

 

-

 

 

-

 

 

112

 

 

-

 

 

112

 

Goodwill Impairment

 

-

 

 

-

 

 

-

 

 

-

 

 

13,403

 

 

13,403

 

 

-

 

 

-

 

 

297

 

 

-

 

 

297

 

Adjusted EBITDA

$

17,601

 

$

2,463

 

$

3,849

 

$

3,230

 

$

2,793

 

$

12,336

 

$

3,146

 

$

2,056

 

$

4,175

 

$

3,306

 

$

12,681

 

Revenue

$

148,086

 

$

32,961

 

$

40,539

 

$

40,422

 

$

37,361

 

$

151,283

 

$

37,708

 

$

36,102

 

$

39,169

 

$

37,536

 

$

150,515

 

Adjusted EBITDA Margin

 

11.9

%

 

7.5

%

 

9.5

%

 

8.0

%

 

7.5

%

 

8.2

%

 

8.3

%

 

5.7

%

 

10.7

%

 

8.8

%

 

8.4

%

 

Contacts

Deborah Pawlowski, IRC, Alliance Advisors
Email: dpawlowski@allianceadvisors.com
Phone: 716.843.3908

AstroNova, Inc.

NASDAQ:ALOT

Release Summary
AstroNova, Inc. (Nasdaq: ALOT) Reports Fourth-Quarter and Full-Year Fiscal 2026 Financial Results
Release Versions

Contacts

Deborah Pawlowski, IRC, Alliance Advisors
Email: dpawlowski@allianceadvisors.com
Phone: 716.843.3908

More News From AstroNova, Inc.

AstroNova Announces Review of Strategic Alternatives

WEST WARWICK, R.I.--(BUSINESS WIRE)--AstroNova, Inc. (Nasdaq: ALOT) Announces Review of Strategic Alternatives...

AstroNova Announces Product Identification Segment Key Leadership Appointments

WEST WARWICK, R.I.--(BUSINESS WIRE)--AstroNova, Inc. (Nasdaq: ALOT) Announces Product Identification Segment Key Leadership Appointments...

AstroNova Announces Fourth Quarter & Fiscal Year 2026 Financial Results Conference Call and Webcast

WEST WARWICK, R.I.--(BUSINESS WIRE)--AstroNova, Inc. (Nasdaq: ALOT) Announces Fourth Quarter & Fiscal Year 2026 Financial Results Conference Call and Webcast...
Back to Newsroom